A Study of Elenestinib in Healthy Adult Female Participants

Clinical trial NCT07388511 · COMPLETED

Trial details

NCT number: NCT07388511
Sponsor: Blueprint Medicines Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2026-02-05
Primary completion: 2026-04-02
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.